Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Oct 2010. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 62026001000001117 | Co-danthrusate (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 62026101000001116 | Co-danthrusate | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Co-danthrusate | Is a | Product containing dantron | true | Inferred relationship | Existential restriction modifier | ||
| Co-danthrusate | Is a | Product containing danthron and docusate sodium | false | Inferred relationship | Existential restriction modifier | ||
| Co-danthrusate | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Co-danthrusate | Has active ingredient | Docusate sodium | false | Inferred relationship | Existential restriction modifier | ||
| Co-danthrusate | Has active ingredient | Dantron | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension | Is a | True | Co-danthrusate | Inferred relationship | Existential restriction modifier | |
| Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule | Is a | True | Co-danthrusate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR